Coloplast A/S : Insider tradings - Allocations of share options
January 20, 2017 at 04:59 am
Share
NASDAQ Copenhagen
Report on transactions of executives and related parties in Coloplast shares and related securities
According to the Market Abuse Regulation art. 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.
The below transaction deals with allocation of share options:
19 January 2017
Coloplast A/S Holtedam 1
3050 Humlebaek Denmark
Tel: +45 4911 1111
www.coloplast.com CVR-nr. 69749917
Name
Lars Rasmussen
Reason
CEO
Issuer
Coloplast A/S
ISIN code
DK0060448595
Description
Share options
Transaction
Share option allocation
Trade date
19 January 2017
Market
NASDAQ Copenhagen
Number
105,656
Black & Scholes value per share option DKK
49.69
Market value in DKK
5,250,047
Strike price per share
501.83
Name
Anders Lonning-Skovgaard
Reason
Executive Vice President
Issuer
Coloplast A/S
ISIN code
DK0010309657
Description
Share options
Transaction
Share option allocation
Trade date
19 January 2017
Market
NASDAQ Copenhagen
Number
40,250
Black & Scholes value per share option DKK
49.69
Market value in DKK
2,000,023
Strike price per share
501.83
Name
Kristian Villumsen
Reason
Executive Vice President
Issuer
Coloplast A/S
ISIN code
DK0060448595
Description
Share options
Transaction
Share option allocation
Trade date
19 January 2017
Market
NASDAQ Copenhagen
Number
55,344
Black & Scholes value per share option DKK
49.69
Market value in DKK
2,750,043
Strike price per share
501.83
Name
Allan Rasmussen
Reason
Executive Vice President
Issuer
Coloplast A/S
ISIN code
DK0010309657
Description
Share options
Transaction
Share option allocation
Trade date
19 January 2017
Market
NASDAQ Copenhagen
Number
44,275
Black & Scholes value per share option DKK
49.69
Market value in DKK
2,200,025
Strike price per share
501.83
Calculation of value:
When calculating the value of share options the Black & Scholes formula is applied. The formula is described in Coloplast's annual report.
The strike price is calculated on basis of the average price for all tradings on 30 December 2016 plus 5%.
Kind regards, Coloplast A/S
Anne-Sofie Søegaard
This information is available in Danish and in English, in case of doubt the Danish version prevails. For further information: Anne-Sofie Søegaard, tel. +45 49 11 18 00.
2/2
Coloplast A/S published this content on 19 January 2017 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 20 January 2017 09:59:02 UTC.
Original documenthttps://www.coloplast.com/investor-relations/announcements/2017/?section=Insider-tradings---Allocations-of-share-options_377661
Public permalinkhttp://www.publicnow.com/view/8CF563F845B3FD299E59EB950304472D16171C79
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows:
- hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.;
- ostomy care products (36.8%): bags and equipment used following intestinal operations;
- wound care and skincare products (11.9%): wound dressings, bandages, creams and gels;
- voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc.
Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).